Edesa BiotechEDSA
13F holders, Q1 2026 (March 31)28holders +6
12new positions
7sold out
$5.23avg. 13F price*
At the end of Q1 2026, 28 institutions reported holding Edesa Biotech Inc. (EDSA) in their 13F filings, up 6 from Q4 2025. 12 opened new positions and 7 sold out. The largest holders were Velan Capital Investment Management LP ($4.3M), Rubric Capital Management LP ($3.6M) and Perceptive Advisors LLC ($2.9M).
- Company
- Edesa Biotech Inc.
- CUSIP
- 27966L306
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $4.5M |
| Exits | 7 | $1.3M |
All 13F filers, Q4 2025 → Q1 2026: 1,045,255 shares bought and 1,541,095 shares sold, net −495,840 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Velan Capital Investment Management LP | 2.71% | Add +20.4% | 827,500 | $4.3M |
| Rubric Capital Management LP | 0.04% | No change | 687,500 | $3.6M |
| Perceptive Advisors LLC | 0.06% | New | 563,239 | $2.9M |
| Jane Street Group, LLC | 0.00% | New | 115,721 | $605K |
| Vanguard Capital Management LLC | 0.00% | — | 85,966 | $450K |
| Geode Capital Management, LLC | 0.00% | Add +65.6% | 77,054 | $403K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 38,446 | $201K |
| State Street Corp. | 0.00% | Add +103.3% | 37,979 | $199K |
| Commonwealth Equity Services, LLC | 0.00% | New | 35,003 | $183K |
| Scientech Research LLC | 0.13% | New | 30,534 | $160K |
| Stonepine Capital Management, LLC | 0.14% | Reduce -95.6% | 30,000 | $157K |
| BlackRock, Inc. | 0.00% | New | 27,709 | $145K |
| Virtu Financial LLC | 0.01% | New | 26,275 | $137K |
| Schonfeld Strategic Advisors LLC | 0.00% | New | 19,650 | $103K |
| Scotia Capital Inc. | 0.00% | New | 15,843 | $83K |
| Northern Trust Corp. | 0.00% | New | 14,994 | $78K |
| SBI Securities Co., Ltd. | 0.00% | New | 3,502 | $18K |
| UBS Group AG | 0.00% | Add +72.0% | 2,343 | $12K |
| Royal Bank of Canada | 0.00% | No change | 1,659 | $9K |
| McGuire Capital Advisors Inc. | 0.01% | New | 1,500 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -80.2% | 507 | $3K |
| Citigroup Inc. | 0.00% | New | 487 | $3K |
| Vanguard Global Advisers, LLC | 0.00% | — | 162 | $847 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 142 | $792 |
| Danske Bank A/S | 0.00% | No change | 1 | $5 |
| LRI Investments, LLC | 0.00% | No change | 1 | $5 |
| Dogwood Wealth Management LLC | 0.00% | No change | 1 | $5 |
| Banque Cantonale Vaudoise | 0.00% | No change | 3 | $0 |
"% of holder's portfolio" is EDSA's weight in each manager's 13F, not the share of Edesa Biotech Inc. the manager owns.